5074 First-line bevacizumab (bev) plus paclitaxel (pac) combination therapy: safety findings (n = 165) from a multicentre German non-interventional study in patients with metastatic breast cancer (MBC)

✍ Scribed by F. Foerster; M. Geberth; C. Schumacher; A. Schneeweiss; R. Weinberg; L. Hahn; M.M. Hertz-Eichenrode; P. Klare; H. Tesch; M. Schmidt

• Book ID: 119600724
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 51 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(09)70966-8